Johnson & Johnson JNJ
NYSE JNJ
$256.10 -2.70 (-1.04%)
At close: Oct 2, 2026 · 4:00 PM EDT

Johnson & Johnson (JNJ) Total Non-Current Liabilities (2009 - 2026)

Updated

Johnson & Johnson's Total Non-Current Liabilities was $105.99 billion in Q2 2026, up 1.3% from $104.65 billion a year earlier but down 3.2% from the prior quarter.

Analysis

Johnson & Johnson (JNJ) Total Non-Current Liabilities (2009 - 2026) Analysis & Trends

At the end of FY2025, Total Non-Current Liabilities at Johnson & Johnson came in at $107.8 billion, up 18.4% from FY2024.

  • Total Non-Current Liabilities shows a four-year compound annual growth rate of 2.0% (FY2021 to FY2025).
  • In earlier years, Total Non-Current Liabilities was $91.07 billion in FY2024 (+6.7%), $85.39 billion in FY2023 (-15.0%), $100.43 billion in FY2022 and $99.67 billion in FY2021.
  • Quarterly Total Non-Current Liabilities has moved between $81.27 billion (Q3 2023) and $110.68 billion (Q1 2023) over five years.
  • Compared with a year earlier, Total Non-Current Liabilities has increased for eight straight quarters, with growth averaging 10.9% over the last eight quarters.
  • The best year-over-year quarter for Total Non-Current Liabilities over five years was Q1 2025 (growth of 21.0%); the worst was Q1 2024 (a decline of 21.5%).
  • Per Business Quant data, JNJ's Total Non-Current Liabilities in the three quarters before Q2 2026 was $109.5 billion (Q1 2026), $107.8 billion (Q4 2025) and $103.61 billion (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 60.66 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 105.99 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 106.45 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 80.25 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn 48.34 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn -967.00 Mn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 81.11 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 36.04 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 100.86 Bn
10 Vertex Pharmaceuticals 128.38 Bn 100.39 Bn 2.84 Bn 5.92 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 28, 2026 105.99 Bn
Mar 29, 2026 109.50 Bn
Dec 28, 2025 107.80 Bn
Sep 28, 2025 103.61 Bn
Jun 29, 2025 104.65 Bn
Mar 30, 2025 105.13 Bn
Dec 29, 2024 91.07 Bn
Sep 29, 2024 93.21 Bn
Jun 30, 2024 95.46 Bn
Mar 31, 2024 86.88 Bn
Dec 31, 2023 85.39 Bn
Oct 1, 2023 81.27 Bn
Jul 2, 2023 100.70 Bn
Apr 2, 2023 110.68 Bn
Jan 1, 2023 100.43 Bn
Oct 2, 2022 90.61 Bn
Jul 3, 2022 90.84 Bn
Apr 3, 2022 93.15 Bn
Jan 2, 2022 97.31 Bn
Oct 3, 2021 97.78 Bn
API Access

Johnson & Johnson Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=JNJ&period=max&api_key=YOUR_API_KEY